PharmaRoth Labs, Inc.
ROTH · OTC
6/30/2017 | 6/30/2016 | 6/30/2015 | 6/30/2014 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $2 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $2 | $2 | $3 |
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | -31.1% | 202.9% | -83.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 40% | 41% | 31% | 59.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -50.4% | -88.4% | -425.4% | -55.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -50.4% | -88.4% | -425.1% | -55% |
| EPS Diluted | -0 | -0.001 | -0.001 | -0.001 |
| % Growth | 66.7% | 50% | -20% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | $0 | $0 | $0 |